9 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

INTRODUCTION According to the World Health Organization (WHO), the big three infectious diseases, namely human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS), malaria and tuberculosis (TB), are reported to be the cause of approximately 2.5 million annual fatalities worldwide. , , , Moreover, the...

  • Infectious Disease
  • Diagnostics
  • World
  • APAC
  • Infectious Disease Incidence

The APAC point of care diagnostics market is expected to grow from US$ 6,548.48 million in 2021 to US$ 15,641.78 million by 2028; it is estimated to grow at a CAGR of 13.2% from 2021 to 2028. The growing use of home-based poc devices is expected to surge the market.The increasing awareness about point of care testing is bringing the...

  • Point Of Care Testing
  • Diagnostics
  • Infectious Disease
  • APAC
  • Diabetes Prevalence
  • Cancer Incidence

Point of Care POC Infectious Disease Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Point of Care POC Infectious Disease Diagnostics...

  • Infectious Disease
  • Diagnostics
  • Managed Care
  • APAC
  • Central America

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease - Pipeline Review, H1 2020, provides an overview of the Chagas Disease (Infectious Disease) pipeline landscape. Chagas disease or...

  • Autoimmune Disease
  • United States
  • Prescription Drug Sales
  • Medical Technology Density

The global plant-based vaccines market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021, growing at a CAGR of 12.9 % from 2021 to 2028. Increasing research & development (R & R&D) activities and the growing prevalence of infectious diseases are fueling the market’s growth. However, the potential risk of...

  • Infectious Disease
  • Vaccine
  • World
  • APAC
  • Middle East
  • Health Expenditure
  • Mortality Rate

Summary AnteoTech Ltd (AnteoTech) formerly Anteo Diagnostics Ltd is a leading medical technology company that develops and commercializes healthcare products.The company along with its subsidiaries is a provider of immunoassays, in-vitro diagnostics, and point of care (PoC) tests to entities involved in the life sciences,...

  • Infectious Disease
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Clinical Trial
  • Managed Care
  • United States
  • Medical Devices Sales

Point of Care POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 Global POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities to 2025: By Technology( Lateral Flow, Agglutination Assays, Flow Through, Solid Phase, and Others), By Application( Tropical...

  • Infectious Disease
  • Managed Care
  • Diagnostics
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Summary Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and supplies in vitro diagnostic medical devices.The portfolio of companys products include bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit. It offers expertise...

  • Infectious Disease
  • Diagnostics
  • Clinical Trial
  • United Kingdom
  • Senegal
  • United States
  • West Africa
  • Hospital Admission
  • Medical Devices Sales